Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts

Last updated: April 10, 2025
Sponsor: Massachusetts General Hospital
Overall Status: Completed

Phase

N/A

Condition

Affective Disorders

Depression (Major/severe)

Anxiety Disorders

Treatment

Supportive Psychotherapy (SPT)

Emotion Regulation Therapy - Attention Regulation (AR-ERT)

Clinical Study ID

NCT04225624
2019P003768
1K23MH120351-01A1
  • Ages 18-60
  • All Genders

Study Summary

The investigators are conducting this study to learn more about the cognitive and attentional processes among individuals with three types of repetitive negative thinking (RNT): mental rituals (as seen in obsessive compulsive disorder, OCD), worries (as seen in generalized anxiety disorder, GAD), and ruminations (as seen in major depressive disorder, MDD). Specifically, the investigators are studying whether psychological treatment can help people with RNT who have trouble stopping unwanted thoughts and shifting their attention.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults ages 18-60 years old

  • Right-handed

  • Living in Massachusetts

  • Repetitive Negative Thinking (RNT) in the form of mental rituals, worries, and/ordepressive ruminations is the primary reason for seeking treatment

  • RNT significant enough to warrant intervention

  • Fluent in English, willing to provide informed consent, and willing to comply withthe study protocol

  • Access to a device with an internet connection, camera, and microphone (e.g.,computer, smart phone, tablet)

  • Comfortable and capable of using a computer and completing reaction-time tasks

Exclusion

Exclusion Criteria:

  • History of head injury or neurologic disease, mental retardation, or borderlineintellectual functioning that would interfere with ability to participate in thestudy.

  • Impaired (or uncorrected) vision, medical illness, or medical treatment that wouldinterfere with participation.

  • Active suicidal or homicidal ideation or any features requiring a higher level ofcare.

  • Lifetime psychotic disorder or bipolar disorder

  • Substance or alcohol use disorder that would interfere with treatment.

  • Current Attention Deficit Hyperactivity Disorder (ADHD) that would interfere withattentional tasks.

  • Unstable dose of psychotropic medications or recent discontinuation of psychotropicmedication.

  • Current psychotherapy or plans to initiate such treatment during the study.

  • Previous course of treatment with cognitive behavioral therapy and/ormindfulness/meditation for obsessive compulsive disorder (OCD), generalized anxietydisorder (GAD), or depression.

Study Design

Total Participants: 87
Treatment Group(s): 2
Primary Treatment: Supportive Psychotherapy (SPT)
Phase:
Study Start date:
April 30, 2021
Estimated Completion Date:
April 09, 2025

Study Description

The current study will examine whether enhancing attention regulation skills in a transdiagnostic intervention for repetitive negative thinking (RNT) will significantly improve the target of attentional/cognitive control. Participants will be randomly assigned (like the flip of a coin) to receive eight 60 minute sessions (over 8 weeks) of either: Emotion Regulation Therapy-Attention Regulation (AR-ERT) or Supportive Psychotherapy (SPT). The investigators will use a multi-method approach to measure attentional/cognitive control: (a) behavioral (i.e., eye tracking fixations and reaction time), (b) electrophysiological (i.e., event related potentials), and (c) self-report (i.e., perceived ability to shift and focus attention). They also will examine early signs of treatment efficacy of AR-ERT and SPT and target validation (i.e., whether changes in attentional/cognitive control correlate with changes in RNT and associated symptoms). Participants will receive assessments of these target and outcome measures at baseline (week 0), mid-treatment (week 4), post-treatment (week 8), and 3-month follow-up (week 20). While most of these procedures are conducted virtually (e.g., therapy sessions), some (e.g., eye tracking and electrophysiological assessments) will be performed in-person. Findings could help identify a cross-cutting target that can be engaged to optimize treatment response for individuals with elevated RNT.

Connect with a study center

  • Massachusetts General Hospital

    Boston, Massachusetts 02114
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.